Arm Holdings PLC (NASDAQ:ARM) shares extended gains after Wednesday’s closing bell following a stronger-than-expected March quarter earnings report and an upbeat outlook for the current period.
For the first quarter of fiscal 2027, the company guided revenue to $1.26 billion at the midpoint and adjusted earnings per share of $0.40, compared with analyst estimates of $1.25 billion and $0.36, respectively.
Bumble Inc (NASDAQ:BMBL) shares tumbled about 21% to about $3 after the dating app operator issued weaker-than-expected guidance, overshadowing a first quarter earnings beat.
Bumble forecast second-quarter revenue in the range of $205 million to $213 million, below analyst expectations of around $215 million. The company also guided for adjusted EBITDA of $65 million to $70 million for the period.
Restaurant Brands International (TSX:QSR, NYSE:QSR) reported better-than-expected financial results for the first quarter, supported by international expansion and continued improvement in its Burger King US operations.
Despite the earnings beat, shares fell 5.5% on weakness in its Popeyes and Tim Hortons businesses.
Hut 8 Mining Corp (TSX:HUT, Unlisted (US):HUTMF) shares surged nearly 33% on Wednesday after the cryptocurrency miner-turned-AI infrastructure developer announced a $9.8 billion, 15-year triple-net lease with a high investment-grade tenant, marking a major milestone in the company's strategic shift toward hyperscale AI data center development.
The lease, tied to the company's Beacon Point campus, covers 352 megawatts of engineered capacity built to Nvidia specifications.
CVS Health Corp (NYSE:CVS) shares rose about 6% on Wednesday morning after the retail pharmacy chain reported first quarter financial results that topped Wall Street expectations on both earnings and revenue.
The company posted adjusted earnings per share (EPS) of $2.57, compared with analyst estimates of $2.21.
Shares of Uber Technologies Inc (NYSE:UBER, XETRA:UT8) jumped 8.4% on Wednesday after the ride-hailing and delivery giant reported first-quarter results that beat earnings expectations and issued second-quarter guidance above consensus estimates.
Uber posted first-quarter revenue of $13.2 billion, up 14% year-over-year, slightly below analyst estimates of $13.31 billion. Adjusted earnings per share came in at $0.72, topping the $0.70 consensus estimate and representing a 44% increase from the prior-year period.
Walt Disney Co (NYSE:DIS, XETRA:WDP) reported stronger-than-expected fiscal second-quarter results on Wednesday, driven by improved profitability at its streaming unit and higher guest spending at its theme parks, sending shares up nearly 8%.
The entertainment giant posted revenue of $25.17 billion for the quarter, topping analyst estimates of $24.87 billion and marking a 6.6% increase from the same period a year earlier.
Novo Nordisk (NYSE:NVO) reported first-quarter results that far exceeded analyst estimates on Wednesday, driven by surging demand for its oral weight-loss pill and strong international sales.
Net sales reached $15.2 billion in the quarter, well above the $11.2 billion analysts had forecast.
Strategy Incorporated (NASDAQ:MSTR) shares fell roughly 2% in Wednesday morning trading after the Bitcoin treasury company reported a first-quarter net loss that came in well below analyst expectations, driven by a sharp decline in the value of its digital asset holdings.
The company posted a net loss of $12.54 billion, or $38.25 per diluted share, for the three months ended March 31, 2026, compared to a loss of $4.22 billion, or $16.49 per share, in the same period a year earlier. Analysts had estimated a loss of approximately $18 per share.
Super Micro Computer Inc (NASDAQ:SMCI) shares surged about 18% following its fiscal third-quarter 2026 results, as strong earnings and margin performance outweighed a revenue miss.
For the quarter ended March 31, 2026, Supermicro reported net sales of $10.24 billion, well below estimates of $12.33 billion.
Medicus Pharma (NASDAQ:MDCX) has reported additional results from a pre-specified expanded dataset analysis of its Phase 2 SKNJCT-003 trial, showing a positive dose-response relationship for its Doxorubicin Microneedle Array (D-MNA) in treating nodular basal cell carcinoma (BCC).
The analysis builds on previously disclosed topline results and incorporates biological, histologic, and safety data from a refined group of 69 patients whose diagnoses met the study’s intended inclusion criteria.
Arizona Gold & Silver Inc (TSX-V:AZS, OTCQB:AZASF, FRA:A9J0) reported assay results from four diamond drill holes at its Philadelphia project in Arizona, highlighting multiple high-grade gold and silver intercepts and continued expansion of the Perry Zone mineralization.
The company said the 1,105-metre drill program included three holes targeting up-dip extensions of the high-grade Perry Zone and one deeper step-out hole.
Power Metallic Mines Inc (TSX-V:PNPN, FRA:IVV1, OTCQB:PNPNF) has reported additional assay results from its winter 2026 drilling program, including what it described as its second-best intersection to date at the Lion Zone, as the company advances toward an updated mineral resource estimate (MRE).
The company said infill drilling continues to define and expand the high-grade Lion Zone of its Nisk polymetallic project in Quebec, with results covering approximately 560 metres along the down-plunge extent of the system.
Data centre demand is outstripping supply, margins are expanding, and Wall Street's models may still be too conservative
The numbers Advanced Micro Devices Inc (NASDAQ:AMD, XETRA:AMD) posted on Tuesday were impressive - so much so, the shares shot up 17%. But the more revealing detail was buried in the guidance and the commentary around it: customer forecasts are exceeding AMD's own expectations, and supply, not demand, remains the binding constraint. That is a very different problem to have than the one many investors feared six months ago.